iRobot, Seagen, Horizon gain amid Microsoft win in Activision case
Justin Sullivan

iRobot (NASDAQ:IRBT) jumped 1.5% after the Federal Trade Commission
was defeated in its efforts to block Microsoft's (MSFT) $69 billion acquisition of Activision (ATVI).
iRobot (IRBT) has been waiting to hear if the FTC will sue to block the robot maker's sale to Amazon (AMZN).

Horizon Therapeutics (NASDAQ:HZNP), which was sued by the FTC in May over its planned sale to Amgen (AMGN), ticked up 0.2%.

Seagen (NASDAQ:SGEN), which is waiting for the FTC to decide on its $43 billion planned sale to Pfizer (PFE), ticked up 0.6%. Pfizer last month agreed to pull and refile its merger notification with the FTC over its purchase of cancer drug maker Seagen (SGEN). A pull and refile resets the 30-day clock for the FTC to review the transaction.
Developing story ...